The University of Chicago Header Logo

Connection

Richard Quigg to Humans

This is a "connection" page, showing publications Richard Quigg has written about Humans.
Connection Strength

0.267
  1. Glomerular Diseases Associated With Hepatitis B and C. Adv Chronic Kidney Dis. 2015 Sep; 22(5):343-51.
    View in: PubMed
    Score: 0.017
  2. Complement regulation in renal disease models. Semin Nephrol. 2013 Nov; 33(6):575-85.
    View in: PubMed
    Score: 0.015
  3. If oxidized LDL immune complexes are relevant in diabetic atherosclerosis, shouldn't they also be relevant in diabetic nephropathy? Clin Immunol. 2011 Jun; 139(3):233-4.
    View in: PubMed
    Score: 0.012
  4. Abnormal immune complex processing and spontaneous glomerulonephritis in complement factor H-deficient mice with human complement receptor 1 on erythrocytes. J Immunol. 2010 Sep 15; 185(6):3759-67.
    View in: PubMed
    Score: 0.012
  5. Characterization of novel VEGF (vascular endothelial growth factor)-C splicing isoforms from mouse. Biochem J. 2010 May 27; 428(3):347-54.
    View in: PubMed
    Score: 0.012
  6. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 2008 Dec; 22(12):4126-35.
    View in: PubMed
    Score: 0.010
  7. The many effects of complement C3- and C5-binding proteins in renal injury. Semin Nephrol. 2007 May; 27(3):321-37.
    View in: PubMed
    Score: 0.010
  8. Mouse podocyte complement factor H: the functional analog to human complement receptor 1. J Am Soc Nephrol. 2007 Apr; 18(4):1157-66.
    View in: PubMed
    Score: 0.009
  9. Complement in lupus nephritis: the good, the bad, and the unknown. Semin Nephrol. 2007 Jan; 27(1):69-80.
    View in: PubMed
    Score: 0.009
  10. Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti-neutrophil cytoplasmic antibodies. Kidney Int. 2007 Feb; 71(4):360-5.
    View in: PubMed
    Score: 0.009
  11. The simple design of complement factor H: Looks can be deceiving. Mol Immunol. 2007 Jan; 44(1-3):123-32.
    View in: PubMed
    Score: 0.009
  12. Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics? Kidney Int. 2005 May; 67(5):1692-703.
    View in: PubMed
    Score: 0.008
  13. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol. 2005 May; 16(5):1214-22.
    View in: PubMed
    Score: 0.008
  14. An integrated strategy for the optimization of microarray data interpretation. Gene Expr. 2005; 12(4-6):223-30.
    View in: PubMed
    Score: 0.008
  15. Complement and autoimmune glomerular diseases. Curr Dir Autoimmun. 2004; 7:165-80.
    View in: PubMed
    Score: 0.008
  16. Complement and the kidney. J Immunol. 2003 Oct 01; 171(7):3319-24.
    View in: PubMed
    Score: 0.007
  17. Role of complement and complement regulatory proteins in glomerulonephritis. Springer Semin Immunopathol. 2003 May; 24(4):395-410.
    View in: PubMed
    Score: 0.007
  18. Isolation and characterization of a novel rat factor H-related protein that is up-regulated in glomeruli under complement attack. J Biol Chem. 2002 Dec 13; 277(50):48351-8.
    View in: PubMed
    Score: 0.007
  19. Use of complement inhibitors in tissue injury. Trends Mol Med. 2002 Sep; 8(9):430-6.
    View in: PubMed
    Score: 0.007
  20. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2022 04; 79(4):570-581.
    View in: PubMed
    Score: 0.006
  21. Local complement factor H protects kidney endothelial cell structure and function. Kidney Int. 2021 10; 100(4):824-836.
    View in: PubMed
    Score: 0.006
  22. Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option? Clin Immunol. 2019 01; 198:102-105.
    View in: PubMed
    Score: 0.005
  23. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J Immunol. 1998 May 01; 160(9):4553-60.
    View in: PubMed
    Score: 0.005
  24. Lupus: The microbiome angle. Immunobiology. 2018 Jun - Jul; 223(6-7):460-465.
    View in: PubMed
    Score: 0.005
  25. Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity. Immunol Invest. 2017 Nov; 46(8):816-832.
    View in: PubMed
    Score: 0.005
  26. Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial. PLoS One. 2017; 12(9):e0184789.
    View in: PubMed
    Score: 0.005
  27. Characterization of C3 receptors on cultured rat glomerular endothelial cells. Kidney Int. 1997 Apr; 51(4):1124-32.
    View in: PubMed
    Score: 0.005
  28. C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus. Immunology. 2016 08; 148(4):407-19.
    View in: PubMed
    Score: 0.005
  29. Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1. J Immunol. 1995 Aug 01; 155(3):1481-8.
    View in: PubMed
    Score: 0.004
  30. C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus. Immunology. 2015 Sep; 146(1):130-43.
    View in: PubMed
    Score: 0.004
  31. Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice. Immunology. 2013 Jul; 139(3):328-37.
    View in: PubMed
    Score: 0.004
  32. DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol. 2013 Feb; 24(3):377-84.
    View in: PubMed
    Score: 0.004
  33. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J Immunol. 2011 Feb 01; 186(3):1849-60.
    View in: PubMed
    Score: 0.003
  34. Altered thymic selection by overexpressing cellular FLICE inhibitory protein in T cells causes lupus-like syndrome in a BALB/c but not C57BL/6 strain. Cell Death Differ. 2010 Mar; 17(3):522-33.
    View in: PubMed
    Score: 0.003
  35. Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J Immunol. 2009 May 01; 182(9):5363-73.
    View in: PubMed
    Score: 0.003
  36. New approaches to the treatment of dense deposit disease. J Am Soc Nephrol. 2007 Sep; 18(9):2447-56.
    View in: PubMed
    Score: 0.002
  37. Experimental membranous nephropathy redux. Am J Physiol Renal Physiol. 2005 Oct; 289(4):F660-71.
    View in: PubMed
    Score: 0.002
  38. cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis. Am J Pathol. 2003 Mar; 162(3):991-1000.
    View in: PubMed
    Score: 0.002
  39. The role of the renin-angiotensin system in cholesterol and puromycin mediated renal injury. Am J Med Sci. 2002 Dec; 324(6):296-304.
    View in: PubMed
    Score: 0.002
  40. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10837-42.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.